Home
RMD
RMD News

Latest ResMed Inc. (RMD) News on January 3, 2025

Here's Why You Should Retain HOLX Stock in Your Portfolio Now

Zacks

15 hours ago

Here's Why You Should Retain HOLX Stock in Your Portfolio Now

Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?

Zacks

2 days ago

Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?

Here's Why You Should Hold IART Stock in Your Portfolio Now

Zacks

3 days ago

Here's Why You Should Hold IART Stock in Your Portfolio Now

Here's Why ResMed (RMD) is a Strong Value Stock

Zacks

3 days ago

Here's Why ResMed (RMD) is a Strong Value Stock

Reasons to Retain AMED Stock in Your Portfolio Now

Zacks

4 days ago

Reasons to Retain AMED Stock in Your Portfolio Now

MT Newswires

4 days ago

CICC Initiates ResMed at Outperform With $295 Price Target

Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 56% gain

Simply Wall St.

4 days ago

Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 56% gain

Is CorMedix (CRMD) Stock Outpacing Its Medical Peers This Year?

Zacks

6 days ago

Is CorMedix (CRMD) Stock Outpacing Its Medical Peers This Year?

Growing Biosimilars Business, New Partnerships Support ABT Stock

Zacks

7 days ago

Growing Biosimilars Business, New Partnerships Support ABT Stock

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now

Zacks

7 days ago

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now

Lucid Inks New Partnership With VITALExam: Stock to Gain?

Zacks

8 days ago

Lucid Inks New Partnership With VITALExam: Stock to Gain?

Here's Why You Should Add HAE Stock to Your Portfolio Now

Zacks

10 days ago

Here's Why You Should Add HAE Stock to Your Portfolio Now

Reasons to Add GMED Stock to Your Portfolio Right Now

Zacks

10 days ago

Reasons to Add GMED Stock to Your Portfolio Right Now

Argus Research

10 days ago

RMD: Lowering target price to $243.00

S&P 500 Gains and Losses Today: Chip Stocks Surge as Holiday Trading Week Begins

Investopedia

10 days ago

S&P 500 Gains and Losses Today: Chip Stocks Surge as Holiday Trading Week Begins

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Investopedia

10 days ago

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Top Stock Movers Now: Broadcom, AMD, ResMed, and More

Investopedia

10 days ago

Top Stock Movers Now: Broadcom, AMD, ResMed, and More

3 Reasons Growth Investors Will Love ResMed (RMD)

Zacks

10 days ago

3 Reasons Growth Investors Will Love ResMed (RMD)

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

10 days ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Possible Bearish Signals With ResMed Insiders Disposing Stock

Simply Wall St.

12 days ago

Possible Bearish Signals With ResMed Insiders Disposing Stock

Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?

Investor's Business Daily

13 days ago

Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?

4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025

Zacks

13 days ago

4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025

BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing

Zacks

15 days ago

BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing

With 74% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst the big guns

Simply Wall St.

16 days ago

With 74% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst the big guns

Argus Research

16 days ago

RMD: Lowering target price to $255.00

SNN Stock Might Rise Following FDA Nod for AETOS Stemless

Zacks

17 days ago

SNN Stock Might Rise Following FDA Nod for AETOS Stemless

ZBH Stock Might Rise Following FDA Nod for OsseoFit

Zacks

18 days ago

ZBH Stock Might Rise Following FDA Nod for OsseoFit

We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease

Simply Wall St.

20 days ago

We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease

Why ResMed (RMD) is a Top Value Stock for the Long-Term

Zacks

20 days ago

Why ResMed (RMD) is a Top Value Stock for the Long-Term

MT Newswires

21 days ago

Stifel Initiates ResMed at Hold With $250 Price Target

Zacks.com featured highlights include InterDigital, ResMed, Greenbrier Companies, Charles River Associates and Kontoor Brands

Zacks

21 days ago

Zacks.com featured highlights include InterDigital, ResMed, Greenbrier Companies, Charles River Associates and Kontoor Brands

RMD or PODD: Which Is the Better Value Stock Right Now?

Zacks

21 days ago

RMD or PODD: Which Is the Better Value Stock Right Now?

5 Solid Dividend Growth Stocks to Buy Now

Zacks

22 days ago

5 Solid Dividend Growth Stocks to Buy Now

Argus Research

23 days ago

RMD: Lowering target price to $257.00

QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements

Zacks

25 days ago

QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements

Scoop Up These 3 GARP Stocks to Receive Handsome Returns

Zacks

25 days ago

Scoop Up These 3 GARP Stocks to Receive Handsome Returns

Returns on Capital Paint A Bright Future For ResMed (NYSE:RMD)

Simply Wall St.

a month ago

Returns on Capital Paint A Bright Future For ResMed (NYSE:RMD)

Here is Why Growth Investors Should Buy ResMed (RMD) Now

Zacks

a month ago

Here is Why Growth Investors Should Buy ResMed (RMD) Now

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls

Zacks

a month ago

Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls

ResMed (RMD) Rose 15% in Q3

Insider Monkey

a month ago

ResMed (RMD) Rose 15% in Q3

PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins

Zacks

a month ago

PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins

ZBH Stock Might Rise Following FDA Nod for Knee Implant Component

Zacks

a month ago

ZBH Stock Might Rise Following FDA Nod for Knee Implant Component

Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios

Zacks

a month ago

Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios

Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?

Zacks

a month ago

Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?

4 Medical Product Stocks to Buy From a Prospective Industry

Zacks

a month ago

4 Medical Product Stocks to Buy From a Prospective Industry

Argus Research

a month ago

RMD: Lowering target price to $259.00

Here's Why ResMed (RMD) is a Strong Momentum Stock

Zacks

a month ago

Here's Why ResMed (RMD) is a Strong Momentum Stock

Bruker Stock Might Rise From the Launch of Dimension Nexus AFM

Zacks

a month ago

Bruker Stock Might Rise From the Launch of Dimension Nexus AFM

Is ResMed Inc.'s (NYSE:RMD) Recent Performance Tethered To Its Attractive Financial Prospects?

Simply Wall St.

a month ago

Is ResMed Inc.'s (NYSE:RMD) Recent Performance Tethered To Its Attractive Financial Prospects?

QGEN Stock Dips Despite Launch of Customized dPCR Assay Design Tools

Zacks

a month ago

QGEN Stock Dips Despite Launch of Customized dPCR Assay Design Tools

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

New Alliances to Support STERIS Stock Despite Macro Issues

Zacks

a month ago

New Alliances to Support STERIS Stock Despite Macro Issues

ABT Stock Benefits From First Patient Procedures With TAVI System

Zacks

a month ago

ABT Stock Benefits From First Patient Procedures With TAVI System

Argus Research

a month ago

RMD: Raising target price to $262.00

RMD vs. LMAT: Which Stock Is the Better Value Option?

Zacks

a month ago

RMD vs. LMAT: Which Stock Is the Better Value Option?

International Expansion Supports BSX Stock Amid Macroeconomic Woes

Zacks

a month ago

International Expansion Supports BSX Stock Amid Macroeconomic Woes

ZBH Stock Gains From FDA Nod for Oxford Cementless Partial Knee

Zacks

a month ago

ZBH Stock Gains From FDA Nod for Oxford Cementless Partial Knee

Zacks.com featured highlights include InterDigital, Greenbrier, Leidos, ResMed and Kontoor

Zacks

a month ago

Zacks.com featured highlights include InterDigital, Greenbrier, Leidos, ResMed and Kontoor

NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain

Zacks

a month ago

NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain

5 Top-Ranked Dividend Growth Stocks for Your Portfolio

Zacks

a month ago

5 Top-Ranked Dividend Growth Stocks for Your Portfolio

GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub

Zacks

a month ago

GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub

Chemed Stock Hurt by Roto-Rooter Softness, Macro Issues Dent Growth

Zacks

a month ago

Chemed Stock Hurt by Roto-Rooter Softness, Macro Issues Dent Growth

MDT Stock Gains From FDA Approval for Its InPen App

Zacks

a month ago

MDT Stock Gains From FDA Approval for Its InPen App

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

Zacks

a month ago

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus

Zacks

a month ago

HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus

3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)

Zacks

a month ago

3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

a month ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?

Zacks

a month ago

Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?

ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System

Zacks

a month ago

ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System

BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX

Zacks

a month ago

BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX

ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year

Investor's Business Daily

a month ago

ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year

ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders

Simply Wall St.

2 months ago

ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders

Here's Why You Should Add RMD Stock to Your Portfolio Now

Zacks

2 months ago

Here's Why You Should Add RMD Stock to Your Portfolio Now

Nevro Stock May Gain on the CE Mark Certification for HFX iQ

Zacks

2 months ago

Nevro Stock May Gain on the CE Mark Certification for HFX iQ

Morningstar Research

2 months ago

Analyst Report: ResMed Inc.

Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock

Zacks

2 months ago

Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock

MYGN Stock Might Gain From SneakPeek Availability in Retail Stores

Zacks

2 months ago

MYGN Stock Might Gain From SneakPeek Availability in Retail Stores

Insiders At ResMed Sold US$16m In Stock, Alluding To Potential Weakness

Simply Wall St.

2 months ago

Insiders At ResMed Sold US$16m In Stock, Alluding To Potential Weakness

QGEN Collaborates With McGill University Centre: Stock to Gain?

Zacks

2 months ago

QGEN Collaborates With McGill University Centre: Stock to Gain?

Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours

Zacks

2 months ago

Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours

Argus Research

2 months ago

RMD: Raising target price to $260.00

INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up

Zacks

2 months ago

INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up

ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues

Zacks

2 months ago

ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues

Zacks.com featured highlights include Greenbrier, Walmart, Leidos, InterDigital and ResMed

Zacks

2 months ago

Zacks.com featured highlights include Greenbrier, Walmart, Leidos, InterDigital and ResMed

OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

Zacks

2 months ago

OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

AMN Stock Falls Despite Q3 Earnings & Revenues Beat, Margins Contract

Zacks

2 months ago

AMN Stock Falls Despite Q3 Earnings & Revenues Beat, Margins Contract

PBH Q2 Earnings Match Estimates, Revenues Beat, Shares Rise

Zacks

2 months ago

PBH Q2 Earnings Match Estimates, Revenues Beat, Shares Rise

5 Dividend Growth Stocks to Buy on Trump Win & Fed Rate Cut

Zacks

2 months ago

5 Dividend Growth Stocks to Buy on Trump Win & Fed Rate Cut

With 74% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backing

Simply Wall St.

2 months ago

With 74% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backing

CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised

Zacks

2 months ago

CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

Zacks

2 months ago

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

BDX Stock Gains Following Q4 Earnings Beat and Higher Margins

Zacks

2 months ago

BDX Stock Gains Following Q4 Earnings Beat and Higher Margins

Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall

Zacks

2 months ago

Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall

MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands

Zacks

2 months ago

MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands

Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up

Zacks

2 months ago

Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up

Argus Research

2 months ago

RMD: Raising target price to $258.00

ResMed Announces Participation in the UBS Global Healthcare Conference

GlobeNewswire

2 months ago

ResMed Announces Participation in the UBS Global Healthcare Conference

Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure

Zacks

2 months ago

Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure

HIMS Stock Gains Following In Line Q3 Earnings, Gross Margin Contracts

Zacks

2 months ago

HIMS Stock Gains Following In Line Q3 Earnings, Gross Margin Contracts

Share on Social Networks: